
Mingo Botín, MD, PhD, discusses ESCRS 2026 data on an EDOF IOL in post-LASIK eyes vs non-LASIK controls.

David Mingo Botín, MD, PhD, FEBO, practices in the Cornea and Ocular Surface Department at Hospital Universitario Ramón y Cajal and at IMO Grupo Miranza Madrid, where his clinical focus spans cataract surgery, corneal transplantation, dry eye disease, presbyopia, and laser refractive surgery. He earned his medical degree from the University of Valladolid and a PhD from the University of Alcalá, and he is a Fellow of the European Board of Ophthalmology.

Mingo Botín, MD, PhD, discusses ESCRS 2026 data on an EDOF IOL in post-LASIK eyes vs non-LASIK controls.